COVID-19 Outcomes May Be Worse for People With Learning Disability
Risks for COVID-19-related hospital admission, death higher for people with learning disability registered with a general practice in England
Two Major Health Systems Will Not Administer Controversial Aduhelm
Individual doctors can prescribe Aduhelm, but patients would have to go elsewhere to receive the drug via infusion
Multiple Sclerosis Disease Burden Higher in Black Patients
Both self-reported disability and objective assessments worse for Black patients, independent of socioeconomic status
Late-Life Cognitive Activity May Delay Dementia
Taking up reading, puzzles, and games even in one's 80s may provide cognitive protection
Lawsuits Claim Pesticide Caused Harm to Children’s Brains
Chlorpyrifos is approved for use on more than 80 crops but was banned for household use in 2001
AAN Presents Ethical Considerations Relating to Dementia Care
Timely anticipatory planning in early dementia is crucial to preserve autonomy over future decisions and to reduce caregiver strain
High-Efficacy Therapy May Reduce Relapses in Active SPMS
But no difference in disability progression seen for high-efficacy versus low-efficacy therapy for secondary progressive multiple sclerosis
Medicare Mulls Coverage for Controversial Drug for Alzheimer Disease
CMS says a final decision on coverage is not likely until next spring
Longer Reproductive Window Could Up Risk for Alzheimer Disease
Authors suggest longer exposure to endogenous estrogen may be associated with increased levels of Alzheimer disease biomarkers
Nearly Four in 10 With Mild COVID-19 Report Symptoms Seven Months Later
Fatigue remains the most common symptom among otherwise healthy people
